| Title | Author(s) | Year | View Count |
 | Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) | Sarin, SK; Kumar, A; Almeida, JA; Chawla, YK; Fan, ST; Garg, H; Silva, JH; Hamid, SS; Jalan, R; Komolmit, P; Lau, GK; Liu, Q; Madan, K; Mohamed, R; Ning, Q; Rahman, S; Rastogi, A; Riordan, SM; Sakhuja, P; Samuel, D; Shah, S; Sharma, BC; Sharma, P; Takikawa, Y; Thapa, BR; Wai, CT; Yuen, MF | 2009 | 571 |
 | Final Results of a Phase I/II Dose Escalation Trial of Valtorcitabine in Patients with Chronic Hepatitis B | Lim, SG; Lai, CL; Myers, M; Yuen, RMF; Wai, CT; Lloyd, D; Pietropalolo, K; Zhou, XJ; Chao, G; Brown, NA | 2005 | 131 |
| Final results of a phase I/II dose escalation trial of valtorcitabine in patients with chronic hepatitis B. | Lim, SG; Lai, CL; Myers, M; Yuen, RMF; Wai, CT; Lyoyd, D; Pietropaolo, K; Zhou, XJ; Chao, G; Brown, NA | 2005 | 114 |
| Valtorcitabine provides potent suppression of hepatitis B virus in patients with chronic hepatitis B: Results of a phase I/II clinical trial. | Lai, CL; Brown, NA; Yuen, RMF; Wai, CT; Lloyd, D; Pietropaolo, K; Zhou, XJ; Chao, G; Lim, SG | 2004 | 173 |
|
